Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.47 USD | -3.17% | -5.72% | -3.90% |
05-13 | Recursion Pharmaceuticals Says BioHive-2 AI Supercomputer Completed | MT |
05-10 | Recursion Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.90% | 2.32B | |
+8.21% | 115B | |
+13.10% | 107B | |
-13.63% | 22.31B | |
-3.99% | 21.6B | |
-5.60% | 18.23B | |
-39.93% | 17.62B | |
+7.36% | 14.26B | |
+33.53% | 12.37B | |
-28.37% | 8.28B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Berenberg Bank Adjusts Recursion Pharmaceuticals Price Target to $33 From $42, Maintains Buy Rating